Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cannabinoid receptor 1 (brain) | Starlite/ChEMBL | References |
Homo sapiens | cannabinoid receptor 2 (macrophage) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0056 | 0.0033 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0033 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.4688 | 1 | 1 |
Mycobacterium ulcerans | lipase LipD | 0.004 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0051 | 0.0023 | 0.0023 |
Trypanosoma brucei | hypothetical protein, conserved | 0.004 | 0 | 0.5 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.004 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0051 | 0.0023 | 0.0023 |
Mycobacterium leprae | conserved hypothetical protein | 0.004 | 0 | 0.5 |
Onchocerca volvulus | 0.004 | 0 | 0.5 | |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.4688 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0051 | 0.0023 | 0.0023 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.4688 | 1 | 1 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.4688 | 1 | 1 |
Toxoplasma gondii | cathepsin CPC1 | 0.4688 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0051 | 0.0023 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.004 | 0 | 0.5 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.4688 | 1 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.4688 | 1 | 1 |
Mycobacterium ulcerans | beta-lactamase | 0.004 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.004 | 0 | 0.5 |
Toxoplasma gondii | cathepsin CPC2 | 0.1779 | 0.3741 | 0.3741 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0056 | 0.0033 | 1 |
Onchocerca volvulus | 0.004 | 0 | 0.5 | |
Leishmania major | hypothetical protein, conserved | 0.004 | 0 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0051 | 0.0023 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.004 | 0 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.2909 | 0.6173 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0051 | 0.0023 | 0.7032 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0256 | 0.0465 | 1 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.004 | 0 | 0.5 |
Onchocerca volvulus | 0.004 | 0 | 0.5 | |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0056 | 0.0033 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.004 | 0 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0051 | 0.0023 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | 0.1779 | 0.3741 | 0.3741 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0051 | 0.0023 | 0.7032 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0051 | 0.0023 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 130 nM | Displacement of [3H]CP55940 from recombinant human CB2 receptor expressed in human HEK293 cell membrane after 90 mins | ChEMBL. | 22483967 |
Ki (binding) | = 1200 nM | Displacement of [3H]CP55940 from recombinant human CB1 receptor expressed in human HEK293 cell membrane after 90 mins | ChEMBL. | 22483967 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.